Literature DB >> 10777386

TR3 death receptor expression in the normal and ischaemic brain.

D C Harrison1, J Roberts, C A Campbell, B Crook, R Davis, K Deen, J Meakin, D Michalovich, J Price, M Stammers, P R Maycox.   

Abstract

Members of the death receptor family may play a prominent role in developmental and pathological neuronal cell death. We report the expression of the TR3 and TR7 death receptors in the adult human and rat central nervous system. Whereas expression of TR3 appears to be high in the human cerebellum, with lower levels in other brain regions, robust expression is observed in many regions of the rat brain. We also analyzed modulation of death receptor expression in an in vivo rat model of acute stroke. In contrast to tumor necrosis factor receptor 1, Fas and p75(NGFR), which all show up-regulation specifically in lesioned cortex of the permanent middle cerebral artery occlusion model of stroke. TR3 shows a rapid global increase in both lesioned and unlesioned brain. In comparison, the recently described death receptor TR7 shows no change in this model. These data indicate that the death receptors show clear differences in patterns of expression in response to ischemic injury. ¿ 2000 IBRO. Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777386     DOI: 10.1016/s0306-4522(99)00502-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Death receptor 5 and neuroproliferation.

Authors:  Yanli Niu; Yongqiang Li; Jianfeng Zang; Hongen Huang; Jiexin Deng; Zhanjun Cui; Dongming Yu; Jinbo Deng
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

2.  Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.

Authors:  Barbara Cannella; Stefanie Gaupp; Kakuri M Omari; Cedric S Raine
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

3.  BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia.

Authors:  N Plesnila; S Zinkel; D A Le; S Amin-Hanjani; Y Wu; J Qiu; A Chiarugi; S S Thomas; D S Kohane; S J Korsmeyer; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 4.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

Review 5.  Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

Authors:  Brigitte Onténiente; Sowmyalakshmí Rasika; Alexandra Benchoua; Christelle Guégan
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

Review 6.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

7.  Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants.

Authors:  Rafia S Al-Lamki; Jun Wang; Sathia Thiru; Nicholas R Pritchard; J Andrew Bradley; Jordan S Pober; John R Bradley
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 8.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

9.  Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3.

Authors:  Jason Peter Twohig; Malcolm I Roberts; Nuria Gavalda; Emma L Rees-Taylor; Albert Giralt; Debbie Adams; Simon P Brooks; Melanie J Bull; Claudia J Calder; Simone Cuff; Audrey A Yong; Jordi Alberch; Alun Davies; Stephen B Dunnett; Aviva M Tolkovsky; Eddie C Y Wang
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

10.  The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins.

Authors:  Zulfiqar F Cheema; Daniel R Santillano; Stephen B Wade; Joseph M Newman; Rajesh C Miranda
Journal:  BMC Neurosci       Date:  2004-03-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.